RTA 408 in the Treatment of Advanced Solid Tumors (NSCLC & Melanoma) - DISCOVER

Clinical trial NCT02029729 · COMPLETED

Trial details

NCT number: NCT02029729
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic or Incurable Non-small Cell Lung Cancer Relapsed, Refractory Melanoma

Start date: 2013-12-31
Primary completion: 2015-10-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.